Phibro Animal Health Corporation revised earnings guidance for the fiscal year ending June 30, 2023. For the year, the company expects net sales of $960 million - $1 billion (unchanged); net income of $34 million- $38 million, from $39 million- $43 million; diluted EPS of $0.84 - $0.94, from $0.96 - $1.06.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.98 USD | -1.48% | +1.58% | +55.27% |
09/05 | Transcript : Phibro Animal Health Corporation, Q3 2024 Earnings Call, May 09, 2024 | |
08/05 | Earnings Flash (PAHC) PHIBRO ANIMAL HEALTH CORPORATION Posts Q3 EPS $0.31, vs. Street Est of $0.29 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.27% | 73Cr | |
-11.98% | 7.93TCr | |
+13.86% | 839.12Cr | |
+25.75% | 373.71Cr | |
-0.70% | 327.06Cr | |
+15.03% | 169.15Cr | |
-6.22% | 156.28Cr | |
-23.36% | 128.57Cr | |
-0.98% | 127.71Cr | |
-12.76% | 114.44Cr |
- Stock Market
- Equities
- PAHC Stock
- News Phibro Animal Health Corporation
- Phibro Animal Health Corporation Revises Earnings Guidance for the Fiscal Year Ending June 30, 2023